Govt Job: For M.Pharm at PGIMER – Pay Rs. 60,000 pm

The PGIMER Chandigarh invites applications for the post of following:

Post: Research Fellow (Number of posts = 01)

The following post is required to be filled under the above-mentioned project on a contract basis:

Project Title: Centre for Health Insurance Evidence Synthesis and Financing (CHIEF)

Qualifications :
Essential:– Educational: Master’s degree in Public Health / Health Management / Master of Pharmacy.

Experience: 1 year of experience working in the field of Health Financing/ Economic Evaluation.

Publications: At least 1 publication in the indexed journals in the field of Health Economics/ Health Financing / Economic Evaluation.

Desirable:– Excellent data management and analysis skills.

Emoluments per month (in Rs.) : Rs. 60,000/-

Terms of reference: The candidates who are willing to serve for the entire duration of the project should apply for the above-mentioned position.

How to apply
Interested candidates should submit their curriculum vitae with supporting documents to Room No-004, Department of Community Medicine and School of Public Health, PGIMER, Chandigarh by 24lh November 2022 before 5:00 PM.

Interview schedule:-26th November 2022 at 09:00 AM (A written screening test will be conducted prior to the interview).

Venue: Department of Community Medicine and School of Public Health, PGIMER, Sector- 12, Chandigarh.

Related Posts

  • Pharma
  • June 24, 2025
  • 83 views
Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…

  • Pharma
  • June 24, 2025
  • 81 views
India’s herbal and ayurvedic OTC market set to outpace global growth

New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India

India’s herbal and ayurvedic OTC market set to outpace global growth

India’s herbal and ayurvedic OTC market set to outpace global growth

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug